Displaying 1 - 50 of 13416 results
Released Company Title Industry Topic
28 Feb 2023
22:30 CET
MDXHEALTH MDxHealth to Participate in 43rd Annual Cowen Healthcare Conference 20103010 Biotechnology Meetings / events
28 Feb 2023
18:00 CET
VAN DE VELDE VAN DE VELDE : Inkoop eigen aandelen 40204020 Clothing and Accessories Other subject
28 Feb 2023
18:00 CET
VAN DE VELDE VAN DE VELDE : Acquisition of treasury shares 40204020 Clothing and Accessories Other subject
28 Feb 2023
18:00 CET
VGP VGP NV: Voting Rights and Denominator 35101010 Real Estate Holding and Development Change in Capital
28 Feb 2023
18:00 CET
VGP VGP NV: Stemrechten en Noemer 35101010 Real Estate Holding and Development Change in Capital
28 Feb 2023
17:55 CET
BIOCARTIS Press release Biocartis Group NV: Disclosure of Outstanding Voting Securities 20101025 Health Services Other subject
28 Feb 2023
17:55 CET
BIOCARTIS Persbericht Biocartis Group NV: Openbaarmaking van uitstaande stemrechtverlenende effecten 20101025 Health Services Other subject
28 Feb 2023
15:00 CET
ECONOCOM GROUP ECONOCOM: Convocation d'une Assemblée Générale Ordinaire et d'une Assemblée Générale Extraordinaire pour le 31 mars 2023 10101010 Computer Services Legal
28 Feb 2023
15:00 CET
ECONOCOM GROUP ECONOCOM: Notice of an Ordinary General Meeting and an Extraordinary General Meeting to be held on 31 March 2023 10101010 Computer Services Legal
28 Feb 2023
08:45 CET
SOLVAY Solvay showcases the leading positions and growth prospects of its Soda Ash business 55201000 Chemicals: Diversified Corporate life
28 Feb 2023
08:45 CET
SOLVAY Solvay présente le positionnement de leader et les perspectives de croissance de son activité Soda Ash & Derivatives 55201000 Chemicals: Diversified Corporate life
28 Feb 2023
08:45 CET
SOLVAY Solvay belicht leidende positie en groeiperspectieven van zijn afdeling Natriumcarbonaat 55201000 Chemicals: Diversified Corporate life
28 Feb 2023
08:37 CET
TITAN CEMENT Programme de rachats d'actions 50101030 Cement Other subject
28 Feb 2023
08:34 CET
TITAN CEMENT Share buyback programme 50101030 Cement Other subject
28 Feb 2023
07:00 CET
ACKERMANS V.HAAREN Ackermans & van Haaren réalise, sur l’ensemble de l’exercice 2022, un bénéfice net de 708,7 millions d’euros 30202000 Diversified Financial Services Income
28 Feb 2023
07:00 CET
ACKERMANS V.HAAREN Ackermans & van Haaren realiseert over het boekjaar 2022 een nettowinst van 708,7 miljoen euro 30202000 Diversified Financial Services Income
28 Feb 2023
07:00 CET
ACKERMANS V.HAAREN Ackermans & van Haaren realised a net profit of 708.7 million euros over the year 2022 30202000 Diversified Financial Services Income
27 Feb 2023
22:01 CET
ARGENX SE argenx Appoints Steve Krognes to Board of Directors 20103010 Biotechnology Other subject
27 Feb 2023
18:09 CET
GBL GBL - Transacties op GBL-aandelen 27-02-2023 30202000 Diversified Financial Services Other financial transaction
27 Feb 2023
18:08 CET
GBL GBL - Transactions sur actions propres 27-02-2023 30202000 Diversified Financial Services Other financial transaction
27 Feb 2023
18:07 CET
GBL GBL - Transactions on GBL shares 27-02-2023 30202000 Diversified Financial Services Other financial transaction
27 Feb 2023
17:40 CET
KBC ANCORA ord Mise à jour du programme de rachat d’actions propres KBC Ancora jusqu’au 24 février 2023 30101010 Banks Other subject
27 Feb 2023
17:40 CET
KBC ANCORA ord Update inkoopprogramma KBC Ancora tot 24 februari 2023 30101010 Banks Other subject
27 Feb 2023
17:40 CET
KBC ANCORA ord Update on share repurchase program KBC Ancora until 24 February 2023 30101010 Banks Other subject
27 Feb 2023
07:24 CET
JENSEN-GROUP Update: Inkoop eigen aandelen 50204000 Machinery: Industrial Other subject
27 Feb 2023
07:22 CET
JENSEN-GROUP Update: share buy back 50204000 Machinery: Industrial Other subject
27 Feb 2023
07:00 CET
ARGENX SE argenx to Present at Upcoming Investor Conferences 20103010 Biotechnology Other subject
24 Feb 2023
18:00 CET
BEKAERT Bekaert: Réglementation en matière de transparence 55102010 Iron and Steel Legal
24 Feb 2023
18:00 CET
BEKAERT Bekaert: Transparency law 55102010 Iron and Steel Legal
24 Feb 2023
18:00 CET
BEKAERT Bekaert: Transparantiewetgeving 55102010 Iron and Steel Legal
24 Feb 2023
08:15 CET
BEKAERT Bekaert - Mise à jour relative au Contrat de Liquidité 55102010 Iron and Steel Legal
24 Feb 2023
08:15 CET
BEKAERT Bekaert - Update over de Liquiditeitsovereenkomst 55102010 Iron and Steel Legal
24 Feb 2023
08:15 CET
BEKAERT Bekaert - Update on the Liquidity Agreement 55102010 Iron and Steel Legal
24 Feb 2023
08:00 CET
TEXAF Texaf: 9% STIJGING VAN DE RECURRENTE BEDRIJFSWINST / VERHOOGDE INVESTERINGSPROGRAMMA 35101010 Real Estate Holding and Development Other subject
24 Feb 2023
08:00 CET
TEXAF Texaf: 9% INCREASE IN RECURRING OPERATING PROFIT / INCREASED INVESTMENT TEMPO 35101010 Real Estate Holding and Development Other subject
24 Feb 2023
08:00 CET
TEXAF Texaf : HAUSSE DU BENEFICE OPERATIONNEL RECURRENT DE 9% / INTENSIFICATION DES INVESTISSEMENTS 35101010 Real Estate Holding and Development Other subject
24 Feb 2023
07:00 CET
BIOCARTIS Persbericht Biocartis Group NV: Biocartis Creëert Nieuw Inschrijvingsrechtenplan en Vernietigt Uitstaande Pool onder Bestaande Inschrijvingsrechtenplannen 20101025 Health Services Other subject
24 Feb 2023
07:00 CET
BIOCARTIS Press release Biocartis Group NV: Biocartis Creates New Share Option Plan and Cancels Outstanding Pool under Existing Share Option Plans 20101025 Health Services Other subject
23 Feb 2023
18:06 CET
BPOST bpost: fourth quarter 2022 results 50206040 Delivery Services Legal
23 Feb 2023
18:04 CET
BPOST bpost: fourth quarter 2022 results 50206040 Delivery Services Legal
23 Feb 2023
18:02 CET
BPOST bpost: fourth quarter 2022 results 50206040 Delivery Services Legal
23 Feb 2023
18:00 CET
SOLVAC NOM(RETAIL) Dividende par action en augmentation de 2,6 % en 2022 par rapport à 2021 55201000 Chemicals: Diversified Change in Capital
23 Feb 2023
18:00 CET
SOLVAC NOM(RETAIL) Increase of 2.6 % of the dividend per share in 2022 compared to 2021 55201000 Chemicals: Diversified Change in Capital
23 Feb 2023
18:00 CET
SOLVAC NOM(RETAIL) Dividend per aandeel stijgt met 2,6 % in 2022 vergeleken met 2021 55201000 Chemicals: Diversified Change in Capital
23 Feb 2023
17:40 CET
ASCENCIO Interim statement at 31/12/2022 - First quarter of financial year 2022-2023 35102045 Retail REITs Income
23 Feb 2023
08:00 CET
EURONAV Euronav presentatie over Bijzondere Algemene Vergadering 50206030 Marine Transportation Other subject
23 Feb 2023
08:00 CET
EURONAV Euronav presentation on Special General Meeting 50206030 Marine Transportation Other subject
23 Feb 2023
07:00 CET
VGP VGP NV: Financial Result for FY2022 35101010 Real Estate Holding and Development Income
23 Feb 2023
07:00 CET
BIOSENIC BioSenic optimizes statistical analysis for its ongoing ALLOB Phase IIb study for high-risk tibial fractures, requiring fewer patients and completes patient recruitment 20103010 Biotechnology Other subject
23 Feb 2023
07:00 CET
BIOCARTIS Press release Biocartis Group NV: Biocartis announces 2022 results and 2023 outlook 20101025 Health Services Other subject